Chemesis International Inc. Subsidiary, Natural Ventures PR, LLC, to Remain Operational During COVID-19 Pandemic
Chemesis International Inc. Announces Closing of CDN $5,000,000 Private Placement and Settlement of Debt
Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa
Alvopetro Announces June Sales Volumes, an Operational Update and Quarterly Natural Gas Pricing Update